Nihon Kohden (OTCMKTS:NHNKY) Shares Gap Down - What's Next?

Key Points

• Nihon Kohden's shares gapped down from a previous close of $11.59 to open at $11.16, reflecting a decline of 1.7% in stock price.
• The company's recent earnings report indicated an EPS of $0.18 with revenue of $439.11 million, along with a net margin of 6.23% and return on equity of 7.20%.
• Nihon Kohden Corporation specializes in the development and manufacturing of medical electronic equipment, including patient monitoring systems and defibrillators, serving markets globally.

Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report) shares gapped down before the market opened on Monday . The stock had previously closed at $11.59, but opened at $11.16. Nihon Kohden shares last traded at $11.16, with a volume of 816 shares trading hands.

Nihon Kohden Stock Down 1.7%

The stock's 50-day moving average price is $12.17 and its 200 day moving average price is $13.19. The firm has a market cap of $1.95 billion, a price-to-earnings ratio of 20.35 and a beta of 0.35.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last announced its quarterly earnings data on Tuesday, May 13th. The company reported $0.18 EPS for the quarter. The business had revenue of $439.11 million during the quarter. Nihon Kohden had a net margin of 6.23% and a return on equity of 7.20%.

About Nihon Kohden

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.